Brief: Marksans Pharma's Manufacturing Facility Has Undergone Inspection From German Health Authorities
01/11/2023 05:42
Nov 1 (Reuters) - Marksans Pharma Ltd MARK.NS :
* CO'S MANUFACTURING FACILITY HAS UNDERGONE INSPECTION FROM
GERMAN
HEALTH AUTHORITIES
* AUTHORITIES HAVE NOT FOUND ANY CRITICAL OR MAJOR
OBSERVATIONS
Source text for Eikon: ID:nNSE1MPrh0
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg